Ligne de temps

Beatrix Meha
Ingénieur(e) de Recherche
16 nov. 2022
publication

Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis.

Lire plus
08 août 2022
publication

Genetically modified macrophages accelerate myelin repair.

Lire plus
01 mars 2022
publication

Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain.

Lire plus
18 août 2021
team

Plateforme de BioImagerie de l’Institut de l’Audition

Lire plus
07 févr. 2018
publication

Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.

Lire plus
01 janv. 2015
publication

Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.

Lire plus
01 juil. 2011
publication

Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia.

Lire plus
19 mai 2011
publication

Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion.

Lire plus
16 sept. 2010
publication

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Lire plus